Navigation Links
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel
Date:12/11/2013

BLUE BELL, Pa., Dec. 11, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, has been invited to participate on an expert panel titled, Ovarian & Cervical Cancer – Evaluating the Role of Immunotherapy Exploring Three Approaches – Dendritic Cells, DNA Plasmids & Liposomal Delivery. Dr. Kim will discuss Inovio's DNA immunotherapy VGX-3100, which was designed to treat cervical pre-cancers and cancers, head & neck cancers, and anogenital cancers caused by human papillomavirus (HPV).

Moderated by Maxim Group Managing Director and Senior Biotechnology Analyst, Jason Kolbert, and sponsored by ProActive Capital Group, this webinar will take place on Wednesday, December 11, at 4:00 pm ET.

Access to this panel discussion can be obtained through the following link: http://bit.ly/1f5r6vT

About Cervical Cancer

Cervical cancer is the most commonly occurring cancer among women in developing countries and is the second most commonly occurring cancer amongst women worldwide. Cervical cancer currently affects 530,000 women worldwide and results in 288,000 deaths annually. According to the World Health Organization, cervical cancer is 100% attributable to human papilloma virus (HPV). Preventive vaccines such as GARDASIL® and CERVARIX® are playing an important role in limiting new HPV infections but cannot protect those already infected by HPV, which is present in an estimated 10% of the global population. In addition, a significant number of girls and women eligible for vaccination are not receiving these preventive vaccines. There is no viable therapeutic vaccine or drug to treat HPV, nor the pre-cancers and cancers caused by HPV.

About VGX-3100

VGX-3100, designed to treat HPV-caused cancers and pre-canc
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Doctors at St. Josephs Hospital Stopping Atrial Fibrillation Cold
2. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
3. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
4. St. Josephs Hospital Expands Advanced Center for Robotic Surgery in Tampa, Adds Single Site Surgery for Gallbladder Removal
5. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
6. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
7. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
8. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
9. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
10. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... used on patients in order to treat dental impairments, ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, the leading ... awarded several new IT value-added reseller (VAR) national contracts ... IT goods and services at lower costs. These include ... services such as initiative assistance and ongoing IT consulting ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 Shire plc ... waived the Office of Fair Trading (OFT) approval condition to the ... Incorporated (NASDAQ: VPHM).   As a result of the ... Shire expects to complete the tender offer on January 24, 2014 ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
...   Sysmex America, Inc., a global leader in medical ... its 200th placement of Sysmex WAM ™ ... WAM is now connecting nearly 600 sites and approximately ... Canada. Sysmex WAM plays a key role in delivering ...
... March 20, 2012   A new Consumer Reports poll shows ... The poll was released just as House and Senate ... governing medical devices and at a time when the ... intense criticism.  The House Energy and ...
Cached Medicine Technology:Sysmex America Achieves Clinical Laboratory Connectivity Milestone 2Consumer Reports Poll: Americans Overwhelmingly Support Strong Medical Device Safety Oversight 2Consumer Reports Poll: Americans Overwhelmingly Support Strong Medical Device Safety Oversight 3Consumer Reports Poll: Americans Overwhelmingly Support Strong Medical Device Safety Oversight 4
(Date:4/24/2014)... substantial proportion of risk for developing autism spectrum disorders ... interconnected biological pathways, according to researchers from the Icahn ... broad study of almost 2,500 families in the United ... "Convergence of Genes and Cellular Pathways Dysregulated in Autism ... American Journal of Human Genetics on April 24. ...
(Date:4/24/2014)... Scientific research at UT Southwestern Medical Center previously ... completely, whereas the adult heart lacks this ability. New ... the heart loses its incredible regenerative capability in adulthood, ... , Yes, oxygen. It is well-known that a major ... throughout the body. But at the same time, oxygen ...
(Date:4/24/2014)... Changes in managing patients before, during and after colorectal ... readmission rates, according to researchers who led a study ... practice, called enhanced recovery, is easier on patients before ... evacuation that are typically prescribed. After surgery, patients are ... possible, leading to faster recoveries. , Among findings published ...
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... A Finnish team of researchers was the first in ... which is a tumour of the jaw. , Ameloblastoma ... recur after treatment. Ameloblastoma is most often found in ... by surgery, often resulting in tissue deficiencies in the ... suitable drug therapy could reduce the need for surgery ...
Breaking Medicine News(10 mins):Health News:Genetic alterations in shared biological pathways as major risk factor for ASD 2Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... Their growths also tend to be on the right side, requiring ... -- Among Hispanics, men are twice as likely as women to ... polyps, a new study in Puerto Rico has found. , The ... 56 percent more likely to have polyps than those younger than ...
... ... endometriosis, diagnosis and treatment options. , ... (PRWEB) May 2, 2010 -- The Endometriosis Foundation of America (EFA) ... Science of Endometriosis: Stem Cells to Radical Excision Surgery”, taking place in New York ...
... VANCOUVER, BRITISH COLUMBIA Reports have suggested that sleep ... (ASDs) are associated with challenging daytime behaviors. ... with ASD confirms these reports and will support the ... to improve behavior, according to researchers from Autism Speaks, ...
... ask children to fast overnight before a cholesterol test. New ... "Cholesterol testing can be very difficult for families," said Asheley ... presented Sunday, May 2 at the Pediatric Academic Societies (PAS) ... fast, this almost always means the child has to return ...
... majority of teens say they have never heard of acetaminophen ... with access to the label instructions despite having taken ... Medical Center Study assessing teens, health literacy. More than 60 ... heard of acetaminophen despite 21 percent of them having taken ...
... include Tylenol, Tylenol Plus, Motrin and Benadryl , SATURDAY, ... Friday recalled more than 40 of its liquid cold ... medications may not meet federal quality standards. , The ... Plus, Motrin, Zyrtec and Benadryl. These medications have been ...
Cached Medicine News:Health News:Colon Polyps More Common in Hispanic Men Than Women 2Health News:Endometriosis Foundation of America to Present Landmark Scientific Symposium in NYC 2Health News:Children may be able to eat before cholesterol test, study shows 2
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...
Medicine Products: